Seguridad y tolerabilidad de etravirina-Reference-Cited by-同舟云学术

Seguridad y tolerabilidad de etravirina

Published:2009-12 Issue: Volume:27 Page:21-26
ISSN:0213-005X
Container-title:Enfermedades Infecciosas y Microbiología Clínica
language:es
Short-container-title:Enfermedades Infecciosas y Microbiología Clínica

Author:

Portilla Joaquín

Publisher

Elsevier BV

Subject

Microbiology (medical)

Reference34 articles.

1. New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections;Pauwels;Curr Opin Pharmacol,2004

2. Delavirdine. A review of its use in HIV infection;Scott;Drugs,2000

3. Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors;Rivero;J Antimicrob Chemother,2007

4. Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009);Enferm Infecc Microbiol Clin,2009

5. Randomized, controlled study of the effects of short course of prednisone on the incidence of rash associated with nevirapine in patients infected with HIV-1;Montaner;J Acquir Immene Defic Syndr,2003

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiretroviral Therapy-Induced Dysregulation of Gene Expression and Lipid Metabolism in HIV+ Patients: Beneficial Role of Antioxidant Phytochemicals;International Journal of Molecular Sciences;2022-05-17

2. The Burden of Liver Disease in Human Immunodeficiency Virus-Infected Patients;Seminars in Liver Disease;2012-05

3. Prevalence of TMC278 (rilpivirine) associated mutations in the Frankfurt Resistance Database;Journal of Clinical Virology;2012-03

4. Cardiovascular Disease and Therapeutic Drug-Related Cardiovascular Consequences in HIV-Infected Patients;American Journal Cardiovascular Drugs;2011-12